首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1319141

全球自動輸血系統市場 - 2023-2030 年

Global Autotransfusion System Market - 2023-2030

出版日期: 2023年07月31日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

全球自體輸血系統市場規模在2022 年達到3.214 億美元，預計到2030 年將達到4.826 億美元，2023-2030 年的年複合成長率為5.3%。

自體輸血是指輸血者接受自身血液，而非血庫中的異體（分離供體）血液。自體輸血的目的仍然是保持無菌環境、防止採集的血液凝固、過濾血液並輸給病人。

市場動態

血管手術的增加推動了自動輸血系統市場的發展

推動自體輸血市場發展的主要因素是血管手術數量的增加。越來越多的人罹患血管疾病，為了避免排斥反應，人們開始使用自體輸血治療。

例如，根據《血管外科雜誌》的統計，每年要進行107 例手術。在確定的血管外科醫生群體中，11%的人進行了200 多例手術，21%的人進行了不到50 例手術。一名血管外科醫生平均每年進行107 例血管手術。因此，血管手術數量的增加正在促進市場成長。

技術進步推動全球自體輸血系統市場成長

自體輸血新技術的引入和發展推動了自體輸血系統市場的發展。例如，美國國立衛生研究院（NIH）在2022 年公佈的一項研究中指出，一種醫療設備旨在收集和清洗術中採集的血液，以便在整個過程結束時獲得濃縮的血液製品。

該設備通過中空纖維整合了創新的過濾技術，不僅能濃縮紅細胞，還能濃縮血液製品中的血小板，並清除污染物。

缺乏熟練的專業人員進行操作會阻礙市場成長

能夠更好地執行自動輸血系統的熟練專業人員數量較少，這將阻礙市場的成長。隨著各種手術數量的增加，需要大量專業人員來治療病人。因此，技術熟練的專業人員數量減少會降低市場成長。

COVID-19 影響分析

COVID-19 大流行對自體輸血市場產生了負面影響。許多自體輸血中心和診斷中心關閉，影響了大量患者，輸血率也隨之下降。自體輸血治療被推遲，造成了嚴重的健康問題。

俄烏戰爭影響分析

據估計，俄烏衝突對全球自體輸血系統市場的影響不大，因為該地區的主要市場參與者較少。不過，在預測期內，原料進出口的影響預計對全球自體輸血系統市場的成長影響不大。

Market Overview

Global Autotransfusion System Market reached US$ 321.4 million in 2022 and is expected to reach US$ 482.6 million by 2030 growing with a CAGR of 5.3% during the forecast period 2023-2030.

Autotransfusion is a process wherein a person receives their own blood for a transfusion instead of banked allogenic (separate-donor) blood. The goal of autotransfusion remains the same, to maintain a sterile field, prevent clotting of the collected blood, filtration of the blood, and administration to the patient.

Market Dynamics

An Increase in the Incidence of Vascular Surgeries is Driving the Autotransfusion System Market

The major factor that is driving the autotransfusion market is the increase in the number of vascular surgeries. A number of people are suffering from vascular diseases, which are leading to autotransfusion treatment in order to avoid rejection.

For instance, according to the Journal of Vascular Surgery, 107 operations were performed annually. Among the defined cohort of vascular surgeons, 11% performed more than 200 procedures, and 21% performed fewer than 50. On average, 107 vascular procedures were performed annually by a vascular surgeon. Thus, increase in the number of vascular surgeries is increasing the market growth.

The rise in Technological Advancements is Demanding the Global Autotransfusion System Market Growth

The introduction of new technologies and developments in autotransfusion has been the drive for the autotransfusion system market. For instance, in 2022, NIH revealed a study stating that a medical device intended to collect and wash intra-operatively collected blood to obtain a concentrated blood product at the end of the process.

The device integrates an innovative filtration technology through hollow fibers, allowing RBCs concentration but also platelets within the concentrated blood product and contaminant elimination.Thus technological developments havebeen a drive for the autotransfusion system market.

A lack of Skilled Professionals to Perform the Procedure can Hamper the Market Growth

Less number of skilled professionals to perform the autotransfusion system better will decline the growth of the market. As there is an increase in the number of different kinds of surgeries there is a need foran ample number of professionals to treat the patients. Thus reduced count of skilled professionals can decline the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic epidemic has had a negative impact on the autotransfusion market. Many of the autotransfusion centers and diagnostic centers were closed, which has affected a large number of patients, and the transfusion rate has declined. The autotransfusion treatments have been postponed, which has created severe health issues This resulted in a significant increase in the number of patients lacking the treatment.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global autotransfusion system market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global autotransfusion system market growth over the forecast period.

Segment Analysis

The global autotransfusion system market is segmented based on product type, techniques, application, and end user.

The Cardiology Segment Holds the Dominant Position in the Market Over Forecast Period

Cardiology holds the most significant market share of around 41.7% during the forecast period. Autotransfusion of blood aspirated from the pericardium enables the operator to maintain hemodynamic stability (until surgery can be performed) and attempt to seal the cardiac perforation despite substantial and persistent fluid accumulation.

For instance, according to Lifespan Organization, there are about 500,000 open heart surgeries performed each year. It is most often used for complicated procedures, such as coronary artery bypass, or complex procedures to the aorta or the heart itself. An increase in surgeries required autotransfusion to be raised. Thus, the above factors are influencing the growth of the segment.

Geographical Analysis

Europe accounted for 27.9% of the Market Share Owing to the Prevalence of Surgeries and Increasing Technological Advancements

Due to the increased cardiac surgeries in this region ,there is an ample need for autotransfusion to be performed. The increase in the requirement for autotransfusion has increased the development of autotransfusion systems which has influenced the growth of the autotransfusion market in these regions.

For instance, according to CDS, 38 900 heart bypasses were conducted in Germany in 2020; this was more than double the number in any of the other EU Member States (16 400 were conducted in France). Hypertension is on the rise in Europe, especially in the rural and urban populations, which is increasing the incidence of cardiac surgeries.

Competitive Landscape

The major global players in the autotransfusion market include: BD, Fresenius Kabi, Zimmer, Armstrong Medical, Beijing ZKSK Technolgy, Haemonetics, LivaNova, Terumo BCT, Atrium Medical Corporation, Medtronic among others.

Why Purchase the Report?

To visualize the global autotransfusion system market segmentation based on product type, techniques, application, and end-user, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global autotransfusion system market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global autotransfusion system market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by End User
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increase in incidence of surgeries with maximum blood loss
  - 4.1.1.2. Increase in the unavailability of the donors
- 4.1.2. Restraints
  - 4.1.2.1. High cost of an autotransfusion system
- 4.1.3. Opportunity
  - 4.1.3.1. Technological advancements in product development
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. Russia-Ukraine War Impact Analysis

8. By Product Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.1.2. Market Attractiveness Index, By Product Type
8.2. Intraoperative Autotransfusion Systems*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Postoperative Autotransfusion Systems
8.4. Dual-Mode Autotransfusion Systems
8.5. Autotransfusion Accessories

9. By Techniques

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Techniques
- 9.1.2. Market Attractiveness Index, By Techniques
9.2. Predeposit autologous donation (PAD) *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Acute normovolaemic haemodilution (ANH)
9.4. Perioperative cell salvage (PCS)

10. By Application

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.1.2. Market Attractiveness Index, By Application
10.2. Orthopedic*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Neurology
10.4. Cardiology
10.5. Others

11. By End User

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals *
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Specialty Clinics
11.4. Others

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.2.7.1. U.S.
  - 12.2.7.2. Canada
  - 12.2.7.3. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.3.7.1. Germany
  - 12.3.7.2. U.K.
  - 12.3.7.3. France
  - 12.3.7.4. Spain
  - 12.3.7.5. Italy
  - 12.3.7.6. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.4.7.1. Brazil
  - 12.4.7.2. Argentina
  - 12.4.7.3. Rest of South America
12.5. Asia-Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.5.7.1. China
  - 12.5.7.2. India
  - 12.5.7.3. Japan
  - 12.5.7.4. Australia
  - 12.5.7.5. Rest of Asia-Pacific
12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
- 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles

14.1. Armstrong Medical.
- 14.1.1. Company Overview
- 14.1.2. Product Portfolio and Description
- 14.1.3. Financial Overview
- 14.1.4. Key Developments
14.2. Beijing ZKSK Technology
14.3. Medtronic
14.4. Haemonetics
14.5. LivaNova
14.6. BD
14.7. Zimmer
14.8. Terumo BCT
14.9. Atrium Medical Corporation
14.10. Fresenius Kabi

LIST NOT EXHAUSTIVE